(Q35200818)

7 August 2017

1 reference

title

Pegylation: engineering improved biopharmaceuticals for oncology (English)

1 reference

7 August 2017

Graham Molineux

1

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

7 August 2017

1 reference

7 August 2017

volume

23

1 reference

7 August 2017

issue

8 Pt 2

1 reference

7 August 2017

page(s)

3S-8S

1 reference

Controlled-release, pegylation, liposomal formulations: new mechanisms in the delivery of injectable drugs

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.9.3S.32886

Filgrastim (r-metHuG-CSF) in the 21st century: SD/01.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.9.3S.32886

Pegylated interferon-alpha2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.9.3S.32886

Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.9.3S.32886

Pegylation: engineering improved pharmaceuticals for enhanced therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.9.3S.32886

Peptide and protein PEGylation: a review of problems and solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.9.3S.32886

Characterization and stability of N-terminally PEGylated rhG-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.9.3S.32886

Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.9.3S.32886

Pharmacokinetics of pegfilgrastim

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.9.3S.32886

Safety and efficacy of pegfilgrastim in patients receiving myelosuppressive chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.9.3S.32886

Phase II trial of branched peginterferon-alpha 2a (40 kDa) for patients with advanced renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.9.3S.32886

10.1592/PHCO.23.9.3S.32886

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference